Objective: The Japan NBI Expert Team (JNET) proposed a new narrow band imaging (NBI) classification system for colorectal tumors in June 2014. In this classification system, types 1, 2A, 2B, and 3 correspond to hyperplastic polyps (HPs) including sessile serrated polyps (SSPs), low-grade dysplasia (LGD), high-grade dysplasia (HGD) to shallow submucosal invasive (SM-s) carcinomas, and deep submucosal invasive (SM-d) carcinomas, respectively. Methods: To validate this system, we performed a retrospective image evaluation study, in which 199 colorectal tumors previously assessed by NBI magnifying endoscopy were classified by 3 blinded experienced colonoscopists using the JNET system. The results were compared with the final pathological diagnoses to determine the JNET classification's accuracy. The interobserver agreement was calculated, and the intraobserver agreement was assessed after 6 months. Results: The final pathological diagnoses identified 14 HPs/SSPs, 127 LGDs, 22 HGDs, 19 SM-s carcinomas, and 17 SM-d carcinomas. The respective sensitivities, specificities, positive predictive value, negative predictive value, and accuracies were as follows: Type 1, 85.7, 99.5, 92.3, 98.9, and 98.5%; Type 2A, 96.0, 81.9, 90.3, 92.1, and 90.9%; Type 2B, 75.6%, 90.5, 67.3, 93.4, and 87.4%; and Type 3, 29.4%, 100, 100, 93.8, and 94.0%. The interobserver agreement and the intraobserver agreement were moderate (κ value: 0.52) and excellent (κ value: 0.88), respectively. Lesions presenting as Type 2B during NBI comprised a range of colorectal tumors, including HGDs, SM-s, and SM-d. Conclusions: The JNET classification was useful for the diagnosis of HPs/SSPs, LGDs, and SM-d, but not SM-s lesions. For low-confidence cases, magnified chromoendoscopy is recommended to ensure correct diagnoses.

1.
Gono K, Obi T, Yamaguchi M, et al: Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 2004;9:568-577.
2.
Machida H, Sano Y, Hamamoto Y, et al: Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy 2004;36:1094-1098.
3.
Hirata M, Tanaka S, Oka S, et al: Evaluation of microvessels in colorectal tumors by narrow band imaging magnification. Gastrointest Endosc 2007;66:945-952.
4.
Hirata M, Tanaka S, Oka S, et al: Magnifying endoscopy with narrow band imaging for diagnosis of colorectal tumors. Gastrointest Endosc 2007;65:988-995.
5.
East JE, Suzuki N, Bassett P, et al: Narrow band imaging with magnification for the characterization of small and diminutive colonic polyps: pit pattern and vascular pattern intensity. Endoscopy 2008;40:811-817.
6.
Wada Y, Kashida H, Kudo SE, et al: Diagnostic accuracy of pit pattern and vascular pattern analyses in colorectal lesions. Dig Endosc 2010;22:192-199.
7.
Hewett DG, Kaltenbach T, Sano Y, et al: Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology 2012;143:599-607.
8.
Hayashi N, Tanaka S, Hewett DG, et al: Endoscopic prediction of deep submucosal invasive carcinoma: validation of the Narrow-Band Imaging International Colorectal Endoscopic (NICE) classification. Gastrointest Endosc 2013;78:625-632.
9.
Hattori S, Iwatate M, Sano W, et al: Narrow-band imaging observation of colorectal lesions using NICE classification to avoid discarding significant lesions. World J Gastrointest Endosc 2014;6:600-605.
10.
Rees CJ, Rajasekhar PT, Wilson A, et al: Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study. Gut 2016, DOI: 10.1136/gutjnl-2015-310584.
11.
Sano Y, Tanaka S, Kudo SE, et al: Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc 2016;28:526-33
12.
Bosman FT, Carneiro F, Hruban RH, et al (eds): WHO Classification of Tumors of the Digestive System, ed 4. Lyon, IARC, 2010.
13.
Landis R, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
14.
Sumimoto K, Tanaka S, Shigita K, et al: Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Gastrointest Endosc 2016, DOI: 10.1016/j.gie.2016.07.035.
15.
Fu KI, Sano Y, Kato S, et al: Chromoendoscopy using indigo carmine dye spraying with magnifying observation is the most reliable method for differential diagnosis between non-neoplastic and neoplastic colorectal lesions: a prospective study. Endoscopy 2004;36:1089-1093.
16.
Matsuda T, Fujii T, Saito Y, et al: Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008;103:2700-2706.
17.
Sano Y, Ikematsu H, Fu KI, et al: Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps. Gastrointest Endosc 2009;69:278-283.
18.
Kanao H, Tanaka S, Oka S, et al: Narrow-band imaging magnification predicts the histology and invasion depth of colorectal tumors. Gastrointest Endosc 2009;69:631-636.
19.
Wada Y, Kudo S, Kashida H, et al: Diagnosis of colorectal lesions with the magnifying narrow-band imaging system. Gastrointest Endosc 2009;70:522-531.
20.
Nikami T, Saito S, Tajiri H, et al: The evaluation of histological atypia and depth of invasion of colorectal lesions using magnified endoscopy with narrow-band imaging. Gastroenterol Endosc 2009;51:10-19.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.